These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7864298)
41. [XERODERMA PIGMENTOSUM WITH BASAL CELL AND SPINOCELLULAR EPITHELIOMA AND MELANOMA]. GAUMOND E Hautarzt; 1964 Aug; 15():448-50. PubMed ID: 14249295 [No Abstract] [Full Text] [Related]
42. Fine needle aspiration biopsy of metastatic melanoma. A morphologic analysis of 174 cases. Perry MD; Gore M; Seigler HF; Johnston WW Acta Cytol; 1986; 30(4):385-96. PubMed ID: 3461649 [TBL] [Abstract][Full Text] [Related]
43. Stereologic estimation of volume-weighted mean nuclear volume as a predictor of prognosis in "thin" malignant melanoma. Binder M; Dolezal I; Wolff K; Pehamberger H J Invest Dermatol; 1992 Aug; 99(2):180-3. PubMed ID: 1629630 [TBL] [Abstract][Full Text] [Related]
44. Xeroderma pigmentosum lesions related to ultraviolet transmittance by clothes. Bech-Thomsen N; Wulf HC; Ullman S J Am Acad Dermatol; 1991 Feb; 24(2 Pt 2):365-8. PubMed ID: 1999550 [TBL] [Abstract][Full Text] [Related]
45. Xeroderma pigmentosum showing common skin cancers plus melanocarcinoma controlled by surgery. MOORE C; IVERSON PC Cancer; 1954 Mar; 7(2):377-82. PubMed ID: 13141232 [No Abstract] [Full Text] [Related]
46. The risk of malignant melanoma, internal malignancy and mortality in xeroderma pigmentosum patients. English JS; Swerdlow AJ Br J Dermatol; 1987 Oct; 117(4):457-61. PubMed ID: 3676093 [TBL] [Abstract][Full Text] [Related]
48. Comparative studies on the ultrastructure of malignant melanoma in fish and human by freeze-etching and transmission electron microscopy. Riehl R; Schartl M; Kollinger G J Cancer Res Clin Oncol; 1984; 107(1):21-31. PubMed ID: 6699072 [TBL] [Abstract][Full Text] [Related]
50. Correlation between gender and cytomorphonuclear characteristics in human melanomas and in vitro evidence of sex steroid-induced modifications in the morphonuclear characteristics of three human melanoma cell lines. Loréa P; Decaestecker C; Goldschmidt D; Renard N; André J; Lipski D; Van den Heule B; Salmon I; Darro F; Kiss R Melanoma Res; 1997 Oct; 7(5):382-92. PubMed ID: 9429221 [TBL] [Abstract][Full Text] [Related]
54. Xeroderma pigmentosum observed in a Greenlander. Report of a case complicated by malignant melanoma of the conjunctiva. JENSEN OA Acta Ophthalmol (Copenh); 1962; 40():96-103. PubMed ID: 14451665 [No Abstract] [Full Text] [Related]
55. Pembrolizumab treatment of a patient with xeroderma pigmentosum with disseminated melanoma and multiple nonmelanoma skin cancers. Kraemer KH; Tamura D; Khan SG Br J Dermatol; 2018 May; 178(5):1009. PubMed ID: 29785825 [No Abstract] [Full Text] [Related]
56. Xeroderma pigmentosum: a case report and review of the literature. Feller L; Wood NH; Motswaledi MH; Khammissa RA; Meyer M; Lemmer J J Prev Med Hyg; 2010 Jun; 51(2):87-91. PubMed ID: 21155411 [TBL] [Abstract][Full Text] [Related]
57. Differentiating benign nevi from malignant melanoma using DNA microdensitometry and karyometry and maturation: a zonal comparison, correlation and multivariate analysis. Li LX; Crotty KA; Palmer AA; Kril JJ; Stankovic R; Scolyer RA; McCarthy SW Anal Quant Cytol Histol; 2002 Aug; 24(4):234-43. PubMed ID: 12199325 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of prognostic characteristics of stage I cutaneous malignant melanoma. Tan GJ; Baak JP Anal Quant Cytol; 1984 Sep; 6(3):147-54. PubMed ID: 6508033 [TBL] [Abstract][Full Text] [Related]
59. [Amelanotic melanoma within a giant pigmented nevus. Ultrastructure examinations]. Neumann H; Konrad K Z Hautkr; 1978 Jun; 53(11):381-6. PubMed ID: 664811 [No Abstract] [Full Text] [Related]
60. Impaired humoral and cellular immunity in xeroderma pigmentosum. Wysenbeek AJ; Pick AI; Weiss H; Vana D; Atsmon A Clin Oncol; 1980 Dec; 6(4):361-5. PubMed ID: 7460410 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]